Explore our website
Welcome to the Knowledgebase, an online resource, where you can search for information about allergy.
Around one third of the UK population (approximately 19 million people) will develop an allergy at some time in their lives.
Join us as a member of the Anaphylaxis Campaign today and help us to raise the profile of severe allergy and support those who live with life threatening allergies.
The Anaphylaxis Campaign are the only UK wide charity operating solely for people at risk from severe allergic reactions. Click here to find out who we are, what we do and who supports us.
13th October 2017
Friday 13th October 2017 The Anaphylaxis Campaign has been contacted by some of our supporters who raised concerns about the availability of EpiPen® in the UK. We contacted Mylan UK for information and they have provided us with a statement, which is below. If you have any concerns please speak to your pharmacist or contact […]
5th October 2017
5th October 2017 The Anaphylaxis Campaign has been contacted by several of our supporters about the changes to instruction of the administration EpiPen® and EpiPen® Junior adrenaline. We contacted Mylan UK for clarification and they have provided us with a position statement, please below: Changes to instructions on the administration of EpiPen® and EpiPen® Junior […]
Spare Pens in Schools: Department of Health release guidance on the use of adrenaline auto-injectors in schools
21st September 2017
Updated: 22nd September 2017 The Anaphylaxis Campaign is delighted to share that yesterday the Department of Health released its guidance document “Guidance on the use of adrenaline auto-injectors in schools” to help schools in England develop policies for keeping and using emergency adrenaline auto-injectors (AAIs). The guidance comes prior to new legislation coming into effect […]
12th September 2017
12th September 2017 The Anaphylaxis Campaign has been contacted by several of our supporters who raised concerns about the availability of Emerade® in the UK. We contacted Bausch + Lomb Incorporated who distribute the injector. We understand from our conversation that there is a temporary supply issue of Emerade® 150mcg, 300mcg and 500 mcg doses. […]